169 related articles for article (PubMed ID: 30600607)
1. Next-generation sequencing in precision oncology: Patient understanding and expectations.
Roberts JS; Gornick MC; Le LQ; Bartnik NJ; Zikmund-Fisher BJ; Chinnaiyan AM;
Cancer Med; 2019 Jan; 8(1):227-237. PubMed ID: 30600607
[TBL] [Abstract][Full Text] [Related]
2. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
[TBL] [Abstract][Full Text] [Related]
3. Revisiting Expectations in an Era of Precision Oncology.
Marchiano EJ; Birkeland AC; Swiecicki PL; Spector-Bagdady K; Shuman AG
Oncologist; 2018 Mar; 23(3):386-388. PubMed ID: 29158373
[TBL] [Abstract][Full Text] [Related]
4. Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.
Shirdarreh M; Aziza O; Pezo RC; Jerzak KJ; Warner E
Oncologist; 2021 Aug; 26(8):e1359-e1371. PubMed ID: 33823080
[TBL] [Abstract][Full Text] [Related]
5. Mainstreaming informed consent for genomic sequencing: A call for action.
Bunnik EM; Dondorp WJ; Bredenoord AL; de Wert G; Cornel MC
Eur J Cancer; 2021 May; 148():405-410. PubMed ID: 33784533
[TBL] [Abstract][Full Text] [Related]
6. Parents of a child with epilepsy: Views and expectations on receiving genetic results from Whole Genome Sequencing.
Jaitovich Groisman I; Hurlimann T; Godard B
Epilepsy Behav; 2019 Jan; 90():178-190. PubMed ID: 30583270
[TBL] [Abstract][Full Text] [Related]
7. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings.
Bergner AL; Bollinger J; Raraigh KS; Tichnell C; Murray B; Blout CL; Telegrafi AB; James CA
Am J Med Genet A; 2014 Nov; 164A(11):2745-52. PubMed ID: 25251809
[TBL] [Abstract][Full Text] [Related]
8. Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative study.
Rohrmoser A; Pichler T; Letsch A; Westphalen CB; Keilholz U; Heinemann V; Goerling U; Herschbach P
Psychooncology; 2020 Feb; 29(2):423-429. PubMed ID: 31713281
[TBL] [Abstract][Full Text] [Related]
9. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
[TBL] [Abstract][Full Text] [Related]
10. Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing.
Robinson JO; Carroll TM; Feuerman LZ; Perry DL; Hoffman-Andrews L; Walsh RC; Christensen KD; Green RC; McGuire AL;
J Empir Res Hum Res Ethics; 2016 Feb; 11(1):21-30. PubMed ID: 26928896
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
[TBL] [Abstract][Full Text] [Related]
12. Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
Vashistha V; Poonnen PJ; Snowdon JL; Skinner HG; McCaffrey V; Spector NL; Hintze B; Duffy JE; Weeraratne D; Jackson GP; Kelley MJ; Patel VL
PLoS One; 2020; 15(7):e0235861. PubMed ID: 32706774
[TBL] [Abstract][Full Text] [Related]
13. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
14. Communication about the risks and benefits of phase I pediatric oncology trials.
Hazen RA; Zyzanski S; Baker JN; Drotar D; Kodish E
Contemp Clin Trials; 2015 Mar; 41():139-45. PubMed ID: 25638751
[TBL] [Abstract][Full Text] [Related]
15. Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium.
Zoltick ES; Linderman MD; McGinniss MA; Ramos E; Ball MP; Church GM; Leonard DGB; Pereira S; McGuire AL; Caskey CT; Sanderson SC; Schadt EE; Nielsen DE; Crawford SD; Green RC;
Genome Med; 2019 Feb; 11(1):10. PubMed ID: 30808425
[TBL] [Abstract][Full Text] [Related]
16. Knowledge Is Power: Benefits, Risks, Hopes, and Decision-Making Reported by Parents Consenting to Next-Generation Sequencing for Children and Adolescents with Cancer.
Mandrell BN; Gattuso JS; Pritchard M; Caples M; Howard Sharp KM; Harrison L; Ouma AA; Valdez JM; Johnson LM; Nichols KE
Semin Oncol Nurs; 2021 Jun; 37(3):151167. PubMed ID: 34127338
[TBL] [Abstract][Full Text] [Related]
17. Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
Marron JM; DuBois SG; Glade Bender J; Kim A; Crompton BD; Meyer SC; Janeway KA; Mack JW
Pediatr Blood Cancer; 2016 Nov; 63(11):1974-82. PubMed ID: 27429135
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests.
Dehar N; Abedin T; Tang P; Bebb G; Cheung WY
Curr Oncol; 2022 Dec; 29(12):9916-9927. PubMed ID: 36547194
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Gray SW; Hicks-Courant K; Lathan CS; Garraway L; Park ER; Weeks JC
J Oncol Pract; 2012 Nov; 8(6):329-35, 2 p following 335. PubMed ID: 23598841
[TBL] [Abstract][Full Text] [Related]
20. Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center.
Schwaegermann MK; Schranz M; Moehler M; Labenz C; Moringlane A; Schmidt M; Theobald M; Hess G
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2117-2126. PubMed ID: 33420813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]